- Home
- LUCD vs COYA Comparison
LUCD vs COYA Comparison
Compare LUCD & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- COYA
- Stock Information
- Founded
- LUCD 2018
- COYA 2020
- Country
- LUCD United States
- COYA United States
- Employees
- LUCD N/A
- COYA N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- LUCD Health Care
- COYA Health Care
- Exchange
- LUCD Nasdaq
- COYA Nasdaq
- Market Cap
- LUCD 108.0M
- COYA 107.0M
- IPO Year
- LUCD 2021
- COYA 2022
- Fundamental
- Price
- LUCD $1.20
- COYA $6.40
- Analyst Decision
- LUCD Strong Buy
- COYA Strong Buy
- Analyst Count
- LUCD 5
- COYA 5
- Target Price
- LUCD $3.70
- COYA $16.20
- AVG Volume (30 Days)
- LUCD 1.3M
- COYA 137.0K
- Earning Date
- LUCD 11-12-2025
- COYA 11-05-2025
- Dividend Yield
- LUCD N/A
- COYA N/A
- EPS Growth
- LUCD N/A
- COYA N/A
- EPS
- LUCD N/A
- COYA N/A
- Revenue
- LUCD $4,360,000.00
- COYA $423,452.00
- Revenue This Year
- LUCD $13.90
- COYA $40.80
- Revenue Next Year
- LUCD $163.88
- COYA N/A
- P/E Ratio
- LUCD N/A
- COYA N/A
- Revenue Growth
- LUCD 14.74
- COYA N/A
- 52 Week Low
- LUCD $0.75
- COYA $4.65
- 52 Week High
- LUCD $1.80
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- LUCD 55.37
- COYA 50.61
- Support Level
- LUCD $1.17
- COYA $6.06
- Resistance Level
- LUCD $1.27
- COYA $7.75
- Average True Range (ATR)
- LUCD 0.08
- COYA 0.50
- MACD
- LUCD 0.01
- COYA 0.02
- Stochastic Oscillator
- LUCD 73.08
- COYA 21.79
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.